BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37413947)

  • 1. Simultaneous integrated or sequential boost to clinically involved lymph nodes in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy.
    Kahvecioglu A; Gurlek E; Yedekci FY; Sari SY; Gultekin M; Yildiz F
    Gynecol Oncol; 2023 Sep; 176():10-15. PubMed ID: 37413947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
    Cihoric N; Tapia C; Krüger K; Aebersold DM; Klaeser B; Lössl K
    Radiat Oncol; 2014 Mar; 9():83. PubMed ID: 24661323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
    Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
    Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose simultaneous integrated boost for node positive cervical cancer.
    Jayatilakebanda I; Tsang YM; Hoskin P
    Radiat Oncol; 2021 May; 16(1):92. PubMed ID: 34001158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
    Zhang GY; Zhang R; Bai P; Li SM; Zhang YY; Chen YR; Huang MN; Wu LY
    BMC Cancer; 2022 Dec; 22(1):1331. PubMed ID: 36539745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
    Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
    Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
    Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Toxicity of IMRT-Based Simultaneous Integrated Boost for the Definitive Management of Positive Lymph Nodes in Patients with Cervical Cancer.
    Dang YZ; Li P; Li JP; Zhang Y; Zhao LN; Li WW; Wei LC; Shi M
    J Cancer; 2019; 10(5):1103-1109. PubMed ID: 30854117
    [No Abstract]   [Full Text] [Related]  

  • 10. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
    BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Control and Chemoradiotherapy Dose Response for Clinically Involved Lymph Nodes in Patients with Locally Advanced Endometrial Cancers Who are Not Candidates for Upfront Surgical Staging Extrafascial Hysterectomy.
    Iheagwara UK; Vargo JA; Boisen MM; Taylor SE; Berger JL; Comerci JT; Orr BC; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Courtney-Brooks MB; Beriwal S
    Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):e110-e117. PubMed ID: 32919862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
    Lee YC; Rash DL; Stern RL; Mayadev JS
    Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study.
    Lőcsei Z; Sebestyén K; Sebestyén Z; Fehér E; Soltész D; Musch Z; Mangel LC
    Pathol Oncol Res; 2021; 27():608446. PubMed ID: 34257570
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer.
    Rash DL; Lee YC; Kashefi A; Durbin-Johnson B; Mathai M; Valicenti R; Mayadev JS
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):317-22. PubMed ID: 23906933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.
    Lee J; Lin JB; Sun FJ; Chen YJ; Chang CL; Jan YT; Wu MH
    Medicine (Baltimore); 2017 Mar; 96(10):e6158. PubMed ID: 28272204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life.
    Akbaba S; Oelmann-Avendano JT; Bostel T; Rief H; Nicolay NH; Debus J; Lindel K; Foerster R
    Radiol Oncol; 2018 Sep; 52(3):320-328. PubMed ID: 30210042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.
    Macchia G; Cilla S; Deodato F; Legge F; Di Stefano A; Chiantera V; Scambia G; Valentini V; Morganti AG; Ferrandina G
    Br J Radiol; 2015; 88(1055):20150385. PubMed ID: 26388108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.